Raphael Bernard-Valnet
Overview
Explore the profile of Raphael Bernard-Valnet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marignier R, Villacieros-Alvarez J, Espejo C, Arrambide G, Fissolo N, Gutierrez L, et al.
J Neurol Neurosurg Psychiatry
. 2025 Feb;
PMID: 39939136
Background: Serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) have emerged as important biomarkers in multiple sclerosis (MS) and aquaporin-4 seropositive neuromyelitis optica spectrum disorder (AQP4-NMOSD)....
2.
Baumgartner T, Di Liberto G, Loser V, Vicino A, Theaudin M, Castro-Jimenez M, et al.
Rev Med Suisse
. 2025 Jan;
21(900-1):59-62.
PMID: 39812289
In 2024, therapeutic and diagnostic advancements are shaping the field of neurology. Three new drugs show promise for treating myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. A new classification for...
3.
Villacieros-Alvarez J, Espejo C, Arrambide G, Dinoto A, Mulero P, Rubio-Flores L, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200362.
PMID: 39752619
Objectives: To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. Methods: This...
4.
Mathias A, Perriot S, Jones S, Canales M, Bernard-Valnet R, Gimenez M, et al.
Front Immunol
. 2024 Aug;
15:1419712.
PMID: 39114659
Background And Objectives: Up to 46% of patients with presumed autoimmune limbic encephalitis are seronegative for all currently known central nervous system (CNS) antigens. We developed a cell-based assay (CBA)...
5.
Blant J, De Rossi N, Gold R, Maurousset A, Kraemer M, Romero-Pinel L, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Jul;
11(5):e200281.
PMID: 38991170
Background And Objectives: Progressive multifocal leukoencephalopathy (PML) is a severe neurologic disease resulting from JC virus reactivation in immunocompromised patients. Certain multiple sclerosis (MS) disease-modifying therapies (DMTs) are associated with...
6.
Bernard-Valnet R, Lalive P, Breville G, Theaudin M, Pot C, Du Pasquier R
Rev Med Suisse
. 2024 Apr;
20(871):843-847.
PMID: 38665105
Aging in multiple sclerosis (MS) leads to altered clinical manifestations, where the pathophysiology shifts towards compartmentalized inflammation that drives clinical progression independent of relapse activity. Consequently, the effectiveness of disease-modifying...
7.
Lerusse J, Uginet M, Theaudin M, Bernard-Valnet R, Pot C, Lalive P
Rev Med Suisse
. 2024 Apr;
20(871):828-832.
PMID: 38665102
Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD) is an autoimmune disease responsible for demyelination of the central nervous system that can occur in adults or children. Overlapping phenotypes between MOGAD,...
8.
Akhvlediani T, Bernard-Valnet R, Dias S, Eikeland R, Pfausler B, Sellner J
Eur J Neurol
. 2023 Aug;
30(12):3904-3912.
PMID: 37526048
Background And Purpose: The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), rapidly spread across the globe. Tremendous efforts have been mobilized to create effective antiviral...
9.
Born T, Vassallo P, Golshayan D, Di Liberto G, Brouland J, Egervari K, et al.
Neurology
. 2023 Jul;
101(13):e1382-e1386.
PMID: 37407265
Progressive multifocal leukoencephalopathy (PML) is a severe infection of the CNS occurring in immunocompromised individuals in which large demyelinating lesions are induced by polyomavirus JC (JCV). In the absence of...
10.
Mathias A, Pantazou V, Perriot S, Canales M, Jones S, Oberholster L, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Jan;
10(2).
PMID: 36717268
Background And Objective: Depleting CD20 B cells is the primary mechanism by which ocrelizumab (OCRE) is efficient in persons with multiple sclerosis (pwMS). However, the exact role of OCRE on...